Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) Operating Expenses (2024 - 2025)

Historic Operating Expenses for Abivax (ABVX) over the last 2 years, with Q3 2025 value amounting to -$96.7 million.

  • Abivax's Operating Expenses fell 7100.73% to -$96.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.7 million, marking a year-over-year increase of 19612.21%. This contributed to the annual value of $198.2 million for FY2024, which is 3877.85% up from last year.
  • Per Abivax's latest filing, its Operating Expenses stood at -$96.7 million for Q3 2025, which was down 7100.73% from -$53.9 million recorded in Q2 2025.
  • Abivax's 5-year Operating Expenses high stood at $346.0 million for Q4 2024, and its period low was -$96.7 million during Q3 2025.